Clinical Trial Update: The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2 [Phase 2]

View source ↗

Summary

Notes a Phase 2 trial (Trial 2) of selective personalized radio-immunotherapy for locally advanced non-small cell lung cancer, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Montefiore Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING